Financing
Other Financing
Vertex Pharmaceuticals Other Financing remained flat by 0.0% to $1.10M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 22.2%, from $900.00K to $1.10M. Over 3 years (FY 2021 to FY 2025), Other Financing shows a downward trend with a -13.4% CAGR.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryLeverage
SignalContext dependent
VolatilityStable
First reportedQ4 2016
Last reportedQ4 2025
How to read this metric
Usually represents minor or non-recurring items; significant fluctuations may warrant investigation into non-standard financing arrangements.
Detailed definition
Captures miscellaneous cash flows related to financing activities that do not fit into primary categories like debt issu...
Peer comparison
Varies widely by company depending on accounting policies and the complexity of the capital structure.
Metric ID:
cf_other_financingHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.45M | $1.41M | $1.36M | $1.30M | $400.00K | $700.00K | $1.10M | $1.10M | $1.10M | $1.10M | $3.50M | $900.00K | $900.00K | $900.00K | $800.00K | $700.00K | $1.10M | $1.10M |
| QoQ Change | — | -2.6% | -3.5% | -4.5% | -69.2% | +75.0% | +57.1% | +0.0% | +0.0% | +0.0% | +218.2% | -74.3% | +0.0% | +0.0% | -11.1% | -12.5% | +57.1% | +0.0% |
| YoY Change | — | — | — | — | -72.4% | -50.4% | -19.2% | -15.4% | +175.0% | +57.1% | +218.2% | -18.2% | -18.2% | — | -77.1% | -22.2% | +22.2% | +22.2% |
Range$400.00K – $3.50M
CAGR-6.3%
Avg YoY Growth+15.5%
Median YoY Growth-18.2%
Current Streak2 quarters growth
Other Financing at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's other financing?
- Vertex Pharmaceuticals (VRTX) reported other financing of $1.10M in Q4 2025.
- How has Vertex Pharmaceuticals's other financing changed year-over-year?
- Vertex Pharmaceuticals's other financing increased by 22.2% year-over-year, from $900.00K to $1.10M.
- What is the long-term trend for Vertex Pharmaceuticals's other financing?
- Over 3 years (2021 to 2025), Vertex Pharmaceuticals's other financing has grown at a -13.4% compound annual growth rate (CAGR), from $5.70M to $3.70M.
- What does other financing mean?
- Residual cash flows from financing activities not classified elsewhere.